These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27476694)

  • 1. Pleomorphic Xanthoastrocytoma with Anaplastic Features: Retrospective Case Series.
    Rutkowski MJ; Oh T; Niflioglu GG; Safaee M; Tihan T; Parsa AT
    World Neurosurg; 2016 Nov; 95():368-374. PubMed ID: 27476694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of EZH2 expression, BRAF V600E mutation, and CDKN2A/B deletions in epithelioid glioblastoma and anaplastic pleomorphic xanthoastrocytoma.
    Wang J; Liu Z; Cui Y; Liu Y; Fang J; Xu L; He Y; Du J; Su Y; Zou W; Xu Z; Li G
    J Neurooncol; 2019 Aug; 144(1):137-146. PubMed ID: 31214915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF V600E, TERT, and IDH2 Mutations in Pleomorphic Xanthoastrocytoma: Observations from a Large Case-Series Study.
    Ma C; Feng R; Chen H; Hameed NUF; Aibaidula A; Song Y; Wu J
    World Neurosurg; 2018 Dec; 120():e1225-e1233. PubMed ID: 30240866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.
    Perkins SM; Mitra N; Fei W; Shinohara ET
    J Neurooncol; 2012 Oct; 110(1):99-104. PubMed ID: 22843450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma.
    Tabouret E; Bequet C; Denicolaï E; Barrié M; Nanni I; Metellus P; Dufour H; Chinot O; Figarella-Branger D
    Eur J Surg Oncol; 2015 Dec; 41(12):1685-90. PubMed ID: 26454767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up.
    Ida CM; Rodriguez FJ; Burger PC; Caron AA; Jenkins SM; Spears GM; Aranguren DL; Lachance DH; Giannini C
    Brain Pathol; 2015 Sep; 25(5):575-86. PubMed ID: 25318587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleomorphic xanthoastrocytoma: what do we really know about it?
    Giannini C; Scheithauer BW; Burger PC; Brat DJ; Wollan PC; Lach B; O'Neill BP
    Cancer; 1999 May; 85(9):2033-45. PubMed ID: 10223246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.
    Marton E; Feletti A; Orvieto E; Longatti P
    J Neurol Sci; 2007 Jan; 252(2):144-53. PubMed ID: 17189643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?
    Vaubel R; Zschernack V; Tran QT; Jenkins S; Caron A; Milosevic D; Smadbeck J; Vasmatzis G; Kandels D; Gnekow A; Kramm C; Jenkins R; Kipp BR; Rodriguez FJ; Orr BA; Pietsch T; Giannini C
    Brain Pathol; 2021 Jan; 31(1):20-32. PubMed ID: 32619305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF/MEK Dual Inhibitors Therapy in Progressive and Anaplastic Pleomorphic Xanthoastrocytoma: Case Series and Literature Review.
    Kata K; Rodriguez-Quintero JC; Arevalo OD; Zhang JJ; Bhattacharjee MB; Ware C; Dono A; Riascos-Castaneda R; Tandon N; Blanco A; Esquenazi Y; Ballester LY; Amsbaugh M; Day AL; Zhu JJ
    J Natl Compr Canc Netw; 2022 Nov; 20(11):1193-1202.e6. PubMed ID: 36351333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary multicentric anaplastic pleomorphic xanthoastrocytoma with atypical features.
    Montano N; Papacci F; Cioni B; Gaudino S; Della Pepa GM; Conforti G; Di Bonaventura R; Novello M; Lauriola L; Meglio M
    J Clin Neurosci; 2013 Nov; 20(11):1605-8. PubMed ID: 23827171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis.
    Pahapill PA; Ramsay DA; Del Maestro RF
    Neurosurgery; 1996 Apr; 38(4):822-8; discussion 828-9. PubMed ID: 8692406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic PXA in adults: case series with clinicopathologic and molecular features.
    Schmidt Y; Kleinschmidt-DeMasters BK; Aisner DL; Lillehei KO; Damek D
    J Neurooncol; 2013 Jan; 111(1):59-69. PubMed ID: 23096133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleomorphic xanthoastrocytoma: MR imaging findings in 19 patients.
    Yu S; He L; Zhuang X; Luo B
    Acta Radiol; 2011 Mar; 52(2):223-8. PubMed ID: 21498352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleomorphic xanthoastrocytoma: long-term results of surgical treatment and analysis of prognostic factors.
    Gallo P; Cecchi PC; Locatelli F; Rizzo P; Ghimenton C; Gerosa M; Pinna G
    Br J Neurosurg; 2013 Dec; 27(6):759-64. PubMed ID: 23514331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleomorphic xanthoastrocytoma, anaplastic pleomorphic xanthoastrocytoma, and epithelioid glioblastoma: Case series with clinical characteristics, molecular features and progression relationship.
    Lin Z; Yang R; Zheng H; Li Z; Yi G; Wu Q; Yang C; Huang G
    Clin Neurol Neurosurg; 2022 Oct; 221():107379. PubMed ID: 35932588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation of pleomorphic xanthoastrocytoma and differential diagnosis: case report.
    Watanabe N; Ishikawa E; Kohzuki H; Sakamoto N; Zaboronok A; Matsuda M; Shibuya M; Matsumura A
    BMC Neurol; 2020 Jan; 20(1):21. PubMed ID: 31941461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleomorphic xanthoastrocytomas: institutional experience of 18 patients.
    Oh T; Kaur G; Madden M; Bloch O; Parsa AT
    J Clin Neurosci; 2014 Oct; 21(10):1767-72. PubMed ID: 24950906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in treatment patterns and overall survival between grade II and anaplastic pleomorphic xanthoastrocytomas.
    Rodrigues A; Bhambhvani H; Medress ZA; Malhotra S; Hayden-Gephart M
    J Neurooncol; 2021 Jun; 153(2):321-330. PubMed ID: 33970405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of anaplastic pleomorphic xanthoastrocytoma presenting with tumor bleeding and cerebrospinal fluid dissemination.
    Asano K; Miyamoto S; Kubo O; Kikkukawa T; Yagihashi A; Ohkuma H
    Brain Tumor Pathol; 2006 Apr; 23(1):55-63. PubMed ID: 18095120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.